Trademark: 97764177
Word
BIOLINQ
Status Date
Wednesday, September 18, 2024
Filing Date
Monday, January 23, 2023
Published for Opposition
Tuesday, October 31, 2023
10 Wearable monitors used to measure biometric data for medical use; Glucose meters; wearable devices, namely, continuous glucose sensors for monitoring blood glucose for medical purposes
The mark consists of the word "BIOLINQ" in lower case, fanciful font.
Color is not claimed as a feature of the mark.
Jan 26, 2023
New Application Entered
Feb 12, 2023
New Application Office Supplied Data Entered
Sep 22, 2023
Assigned To Examiner
Sep 23, 2023
Non-Final Action Written
Sep 23, 2023
Non-Final Action E-Mailed
Sep 23, 2023
Notification Of Non-Final Action E-Mailed
Sep 26, 2023
Examiners Amendment -Written
Sep 26, 2023
Examiners Amendment E-Mailed
Sep 26, 2023
Notification Of Examiners Amendment E-Mailed
Sep 26, 2023
Examiner's Amendment Entered
Sep 26, 2023
Approved For Pub - Principal Register
Oct 11, 2023
Notification Of Notice Of Publication E-Mailed
Oct 31, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 31, 2023
Published For Opposition
Jun 21, 2024
Use Amendment Filed
Jun 21, 2024
Teas Statement Of Use Received
Jun 21, 2024
Sou Teas Extension Received
Dec 26, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 21, 2024
Notice Of Approval Of Extension Request E-Mailed
Jun 21, 2024
Sou Extension 1 Filed
Aug 14, 2024
Statement Of Use Processing Complete
Sep 18, 2024
Allowed Principal Register - Sou Accepted
Sep 18, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 14, 2024
Case Assigned To Intent To Use Paralegal
Jun 21, 2024
Sou Extension 1 Granted
Trademark Alertz updated from USPTO on 2030-01-24
